Immuno oriented therapy for mandible fractures in patients at high risk of developing inflammatory complications
Abstract
Comparative clinical and immunological analysis of treatment of 49 patients with fractures of the mandible, receiving traditional therapy and treatment with use of immumomodulator leukinferon is carried out in this work. The results of the study demonstrate, that use of immunocorrection with leukinferon gives high immunological effect in comparison with traditional patients treatment. Positive dynamics of immunological parameters changes at patients is closely correlates with current of a clinical state in posttraumatic period. Use of leukinferon in complex therapy at patients with fracture of the mandible with high risk of inflammatory complications development allows to improve a condition of patients in shorter period and to warn inflammatory complications development.
About the Authors
A. G. Uvarova
«Kuban state medical university» of the Ministry of health care of Russian Federation
Russian Federation
Russian Federation
T. V. Gayvoronskaya
«Kuban state medical university» of the Ministry of health care of Russian Federation
Russian Federation
Russian Federation
V. V. Onopriev
«Kuban state medical university» of the Ministry of health care of Russian Federation
Russian Federation
Russian Federation
V. N. Lovlin
«Kuban state medical university» of the Ministry of health care of Russian Federation
Russian Federation
Russian Federation
T. V. Gerbova
«Kuban state medical university» of the Ministry of health care of Russian Federation
Russian Federation
Russian Federation
References
1. Осипян Э.М. Лечение переломов нижней челюсти методом компрессионно-дистракционного остеосинтеза в комплексе с иммунотерапией. - Ставрополь, 1999. - 167 с.
2. Швырков М.Б., Афанасьев В.В., Стародубцев B.C. Неогнестрельные переломы челюстей. - М.: Медицина, 1999. - 335 с.
3. Andreasen J.O., Jensen S.S., Schwartz O., Hillerup Y. A systematic review of prophylactic antibiotics in the surgical treatment of maxillofacial fractures // J. oral. maxillofac. surg. - 2006. - V. 64. № 1664. - P. 8.
4. Chrcanovic B.R. Factors influencing the incidence of maxillofacial fractures // Oral. maxillofac. surg. - 2012. - V. 16. № 3. - P. 17.
5. De Matos F.P., Arnez M.F., Sverzut C.E., Trivellato A.E. A retrospective study of mandibular fracture in a 40-month period Int // J. oral. maxillofac. surg. - 2010. - V. 39. № 10. - P. 5.
6. Erol B., Tanrikulu R., Görgün B. Maxillofacial fractures. Analysis of demographic distribution and treatment in 2901 patients (25-year experience) // J. craniomaxillofac. surg. -2004. - V. 2. № 308. - P. 13.
7. Gordon P.E., Lawler M.E., Kaban L.B., Dodson T.B. Mandibular fracture severity and patient health status are associated with postoperative inflammatory complications // J. oral. maxillofac. surg. - 2011. - V. 69. № 2191. - P. 7.
8. Hwang K., You S. Analysis of facial bone fractures: An 11-year study of 2,094 patients. Indian // J. plast. surg. - 2010. -V. 43 (1). № 42. - P. 48.
Review
For citations:
Uvarova A.G., Gayvoronskaya T.V., Onopriev V.V., Lovlin V.N., Gerbova T.V. Immuno oriented therapy for mandible fractures in patients at high risk of developing inflammatory complications. Kuban Scientific Medical Bulletin. 2015;(1):119-124. (In Russ.)
Views:
229
Email this article 